PBPIA
Pivotal bioVenture Partners Investment Advisor Portfolio holdings
AUM
$259M
1-Year Est. Return
122.69%
This Fund
S&P 500
1 Year Est. Return
+122.69%
AUM
$259M
AUM Growth
+$85.7M
(+50%)
Holding
12
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Vaxcyte
PCVX
$8.38B
| $63.3M | 24.48% |
1,372,425
|
|
||
2
Oculis Holding
OCS
$1.6B
| $45.7M | 17.67% |
2,288,658
-12,116
|
|
||
3
Arcutis Biotherapeutics
ARQT
$2.94B
| $39.7M | 15.34% |
1,366,624
-753,884
|
|
||
|
EVMN
4
Evommune Inc
EVMN
$791M
| $33M | 12.75% |
+1,926,943
|
|
||
|
ZBIO
5
Zenas BioPharma
ZBIO
$1.36B
| $21.5M | 8.31% |
591,991
-187,054
|
|
||
6
Trevi Therapeutics
TRVI
$1.68B
| $15.7M | 6.08% |
1,256,782
|
|
||
7
Immunome
IMNM
$2.31B
| $15.7M | 6.08% |
732,512
+230,000
|
|
||
|
MPLT
8
MapLight Therapeutics
MPLT
$815M
| $10.7M | 4.15% |
+611,447
|
|
||
|
BIOA
9
BioAge Labs
BIOA
$851M
| $8.64M | 3.34% |
653,374
|
|
||
10
Recursion Pharmaceuticals
RXRX
$1.84B
| $2.44M | 0.94% |
595,518
|
|
||
11
Rallybio
RLYB
$57M
| $1.65M | 0.64% |
300,581
|
|
||
12
Bolt Biotherapeutics
BOLT
$8.35M
| $517K | 0.2% |
94,573
|
|